EXOSOME-TARGETING BISPECIFIC ANTIBODIES

The inventions described herein are directed to bispecific antibodies that are capable of selectively targeting exosomes by specifically binding a first exosome-associated protein and Programmed Death Ligand-1 ("PD-L1") as a second exosome-associated protein. These bispecific antibodies ca...

Full description

Saved in:
Bibliographic Details
Main Authors MORIN MICHAEL J, ROBINSON MATTHEW K
Format Patent
LanguageChinese
English
Published 21.09.2021
Subjects
Online AccessGet full text

Cover

Loading…